BILLY MCBAY: Open Payments
NPI 1659340826 · CONWAY, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,243 in 120 payments from 18 companies in 2025. Trend: 2023 $3,008 · 2024 $2,715 · 2025 $2,243
Food & beverage: $2,243
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 34 | $555 |
| UCB, Inc. | 21 | $461 |
| Amgen Inc. | 23 | $400 |
| AstraZeneca Pharmaceuticals LP | 8 | $177 |
| Mallinckrodt Hospital Products Inc. | 5 | $116 |
| Novo Nordisk Inc | 4 | $79 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| ANI Pharmaceuticals, Inc. | 3 | $69 |
| PFIZER INC. | 3 | $66 |
| Fresenius Kabi USA, LLC | 2 | $49 |
Products named: Bimzelx, RINVOQ, SKYRIZI, KRYSTEXXA, OTEZLA, ACTHAR, ENBREL, FARXIGA.
Industry payments across AR — which companies pay providers there.
